loader image
Tuesday, October 7, 2025
84.1 F
McAllen
- Advertisement -

Dr. Leo Lopez III Wins National Honor

Translate to Spanish or other 102 languages!

Dr. Leo López III
Dr. Leo López III

As originally published by Mega Doctor News in its newsprint edition May 2017

- Advertisement -

In the school of medicine and residency, there are many distinguished dedicated young professionals. Mega Doctor News has met many of them, but one stands out. He is Dr. Leo López III of Rio Grande City that was recently named 2017 National Hispanic Resident of the Year by the National Hispanic Medical Association in Washington D.C. (NHMA)

This award recognizes Residents who have contributed to the health of the Hispanic population. NHMA, is an organization dedicated to empowering Hispanic physicians to be leaders who will help eliminate health disparities and improve the health of Hispanics.

Dr. Lopez is a Senior resident physician with Christus Santa Rosa Family Medicine Residency Program in San Antonio, Texas. At age 28, Dr. Lopez has established himself as a thought leader in his generation. “My hope is to make the word physician synonymous with servant,” he told Mega Doctor News.

- Advertisement -

Outside of his clinical duties he serves as a volunteer physician and clinical Advisor for Corazon Clinic, a free clinic open for homeless patients in downtown San Antonio. With the intent of improving population health in vulnerable areas, he founded a non-profit organization aimed at identifying, intervening, and measuring health disparities in underserved communities.

Leo is also passionate about story telling. In the past, he’s served as an investigative journalist, covering health disparities in the Rio Grande Valley and Guatemala. As the Chief Executive Officer for El Renovatio Films LLC, he’s directed and produced documentary films on location in the Middle East, Japan, and Texas.

He’s also delivered two TEDxTalks on topics spanning access to healthcare to perception amongst communities in conflict. He was recognized for his leadership in health policy as a Leadership Scholar with the Texas Academy of Family Physicians.

Further, Dr. Lopez serves on the board of directors for the non-profit organization “Texas Doctors for Social Responsibility”, where he advocates for access to healthcare for low income families. Over the past six years, Dr. Lopez has organized and served in global health operations in Central America and southern Mexico. His work on ethical considerations for short term delivery of care was recently recognized by the World Congress for Clinical Safety in Rome. Lopez will travel to Italy to share his research and address the World Congress this fall of 2017.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STC & Region One ESC Open More Doors to High School Completion

Homeschooled for most of her life, Edcouch-Elsa senior Ana Trevino put her education on hold two years ago to care for her parents as they battled cancer and to step in as a second mother to her six younger siblings.

Unidos Contra la Diabetes to Host 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair, Nov. 5th

Unidos Contra la Diabetes (UCD) has announced that its 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair is less than a month away. Moises Arjona Jr., MS, CHWI, Collective Impact Director for UCD, reminded community partners and stakeholders of the upcoming event, encouraging participation and support.

DHR Health Breast Cancer Symposium, Oct. 11th 

To support providers in the community, the DHR Health Continuing Medical Education Department will host the Breast Cancer Symposium on Saturday, October 11, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado.

DHR Health Introduces Advanced PSMA-PET Imaging with Illuccix® for Prostate Cancer Care

To support early and accurate detection, DHR Health now offers Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection), a prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging tracer for the detection of prostate cancer.
- Advertisement -
×